ask="22.75"
ask_size="100"
average_daily_volume="191200"
bid="17.65"
bid_size="2100"
book_value="7.04"
change="+1.10"
change_from_200_day_moving_average="7.12"
change_from_50_day_moving_average="4.16"
change_from_52_week_high="-11.47"
change_From_52_week_low="10.30"
change_in_percent="+5.10%"
close="22.65"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.22"
eps_estimate_next_quarter="-0.97"
eps_estimate_next_year="-3.30"
ex_dividend_date="N/A"
float_shares="18671000"
high="22.90"
high_52_weeks="34.12"
last_trade_date="1/4/2017"
last_trade_price="22.65"
last_trade_size="12604"
last_trade_time="4:00pm"
low="21.60"
low_52_weeks="12.35"
market_capitalization="645.86M"
moving_average_200_day="15.53"
moving_average_50_day="18.49"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="34.60"
open="21.60"
pe_ratio="N/A"
peg_ratio="-0.56"
percent_change_from_200_day_moving_average="+45.87%"
percent_change_from_50_day_moving_average="+22.52%"
percent_change_from_52_week_high="-33.62%"
percent_change_from_52_week_low="+83.40%"
previous_close="21.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.06"
price_per_sales="2048.33"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="27.10"
stock_exchange="NGM"
symbol="RVNC"
volume="204634"
weeks_range_52="12.35 - 34.12"
